4.7 Article

Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols

期刊

PHARMACOLOGICAL RESEARCH
卷 66, 期 4, 页码 363-373

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2012.05.010

关键词

Angiogenesis; Small molecule; Antagonist; Epigallocatechin-3-gallate; Epigallocatechin-3,5-digallate; Theaflavin monogallates

资金

  1. NIH [CA138390, CA116099, NS067502]
  2. Department of Defense [DAMD17-01-1-0168]

向作者/读者索取更多资源

Tea contains a variety of bioactive chemicals, such as catechins and other polyphenols. These compounds are thought to be responsible for the health benefits of tea consumption by affecting the function of many cellular targets, not all of which have been identified. In a high-throughput screen for small molecule antagonists of the EphA4 receptor tyrosine kinase, we identified five tea polyphenols that substantially inhibit EphA4 binding to a synthetic peptide ligand. Further characterization of theaflavin monogallates from black tea and epigallocatechin-3,5-digallate from green tea revealed that these compounds at low micromolar concentrations also inhibit binding of the natural ephrin ligands to EphA4 and several other Eph receptors in in vitro assays. The compounds behave as competitive EphA4 antagonists, and their inhibitory activity is affected by amino acid mutations within the ephrin binding pocket of EphA4. In contrast, the major green tea catechin, epigallocatechin-3-gallate (EGCG), does not appear to be an effective Eph receptor antagonist. In cell culture assays, theaflavin monogallates and epigallocatechin-3,5-digallate inhibit ephrin-induced tyrosine phosphorylation (activation) of Eph receptors and endothelial capillary-like tube formation. However, the wider spectrum of Eph receptors affected by the tea derivatives in cells suggests additional mechanisms of inhibition besides interfering with ephrin binding. These results show that tea polyphenols derived from both black and green tea can suppress the biological activities of Eph receptors. Thus, the Eph receptor tyrosine kinase family represents an important class of targets for tea-derived phytochemicals. (C) 2012 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples

Roberta Noberini, Andrea Uggetti, Giancarlo Pruneri, Saverio Minucci, Tiziana Bonaldi

MOLECULAR & CELLULAR PROTEOMICS (2016)

Article Cell Biology

Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation

Antonio Barquilla, Ilaria Lamberto, Roberta Noberini, Susanne Heynen-Genel, Laurence M. Brill, Elena B. Pasquale

MOLECULAR BIOLOGY OF THE CELL (2016)

Article Oncology

PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples

Roberta Noberini, Remi Longuespee, Cristina Richichi, Giancarlo Pruneri, Mark Kriegsmann, Giuliana Pelicci, Tiziana Bonaldi

CLINICAL EPIGENETICS (2017)

Article Biochemistry & Molecular Biology

Extensive and systematic rewiring of histone post-translational modifications in cancer model systems

Roberta Noberini, Daniela Osti, Claudia Miccolo, Cristina Richichi, Michela Lupia, Giacomo Corleone, Sung-Pil Hong, Piergiuseppe Colombo, Bianca Pollo, Lorenzo Fornasari, Giancarlo Pruneri, Luca Magnani, Ugo Cavallaro, Susanna Chiocca, Saverio Minucci, Giuliana Pelicci, Tiziana Bonaldi

NUCLEIC ACIDS RESEARCH (2018)

Article Biochemical Research Methods

Alternative digestion approaches improve histone modification mapping by mass spectrometry in clinical samples

Camilla Restellini, Alessandro Cuomo, Michela Lupia, Marco Giordano, Tiziana Bonaldi, Roberta Noberini

PROTEOMICS CLINICAL APPLICATIONS (2019)

Article Oncology

Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in Cancer

Roberta Noberini, Camilla Restellini, Evelyn Oliva Savoia, Francesco Raimondi, Lavinia Ghiani, Maria Giovanna Jodice, Giovanni Bertalot, Giuseppina Bonizzi, Maria Capra, Fausto Antonio Maffini, Marta Tagliabue, Mohssen Ansarin, Michela Lupia, Marco Giordano, Daniela Osti, Giuliana Pelicci, Susanna Chiocca, Tiziana Bonaldi

CANCERS (2019)

Article Biochemical Research Methods

hSWATH: Unlocking SWATH's Full Potential for an Untargeted Histone Perspective

Laura De Clerck, Sander Willems, Roberta Noberini, Camilla Restellini, Bart Van Puyvelde, Simon Daled, Tiziana Bonaldi, Dieter Deforce, Maarten Dhaenens

JOURNAL OF PROTEOME RESEARCH (2019)

Article Biochemical Research Methods

Enrichment of histones from patient samples for mass spectrometry-based analysis of post-translational modifications

Roberta Noberini, Camilla Restellini, Evelyn Oliva Savoia, Tiziana Bonaldi

METHODS (2020)

Article Biochemistry & Molecular Biology

Epigenetic drug target deconvolution by mass spectrometry-based technologies

Roberta Noberini, Tiziana Bonaldi

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)

Review Biochemical Research Methods

Clinical Application of Mass Spectrometry-Based Proteomics in Lung Cancer Early Diagnosis

Roberto Gasparri, Giulia Sedda, Roberta Noberini, Tiziana Bonaldi, Lorenzo Spaggiari

PROTEOMICS CLINICAL APPLICATIONS (2020)

Article Biochemistry & Molecular Biology

Label-Free Mass Spectrometry-Based Quantification of Linker Histone H1 Variants in Clinical Samples

Roberta Noberini, Morales Cristina Torres, Evelyn Oliva Savoia, Stefania Brandini, Maria Giovanna Jodice, Giovanni Bertalot, Giuseppina Bonizzi, Maria Capra, Giuseppe Diaferia, Paola Scaffidi, Tiziana Bonaldi

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Mass spectrometry-based characterization of histones in clinical samples: applications, progresses, and challenges

Roberta Noberini, Giulia Robusti, Tiziana Bonaldi

Summary: In the past 15 years, research has shown the potential of investigating histone post-translational modifications and variants in clinical samples for discovering biomarkers and therapeutic targets in cancer biology. Mass spectrometry has emerged as a powerful tool for unbiased, comprehensive, and quantitative investigation of histones in clinical samples, with recent advancements in technology expanding its application possibilities. The 'bottom-up' strategy of analyzing short proteolytic peptides has shown success in clinical sample analysis, offering a promising approach for histone PTM profiling.

FEBS JOURNAL (2022)

Article Cell Biology

LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response

Stefania Faletti, Daniela Osti, Elena Ceccacci, Cristina Richichi, Brunella Costanza, Luciano Nicosia, Roberta Noberini, Giulia Marotta, Laura Furia, Mario R. Faretta, Silvia Brambillasca, Micaela Quarto, Luca Bertero, Renzo Boldorini, Bianca Pollo, Sara Gandini, Davide Cora, Saverio Minucci, Ciro Mercurio, Mario Varasi, Tiziana Bonaldi, Giuliana Pelicci

Summary: Glioblastoma (GBM) is a deadly tumor with high aggressiveness, heterogeneity, poor blood-brain barrier penetration, and resistance to therapy, emphasizing the need for new treatment targets. Research shows that LSD1 inhibition can penetrate brain tissue, exhibit anti-tumor activity in GBM TICs, and disrupt stress responses in cells, thereby reducing tumor aggressiveness.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach

Roberta Noberini, Giancarlo Pruneri, Saverio Minucci, Tiziana Bonaldi

DATA IN BRIEF (2016)

暂无数据